PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. vs SQUARE PHARMS PLC: FDA Enforcement Comparison

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. has been the subject of 205 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for SQUARE PHARMS PLC.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.: 0 warning letters, 205 recalls, 0 approval records, 0 Form 483s.

SQUARE PHARMS PLC: 0 warning letters, 0 recalls, 1 approval record, 0 Form 483s.

Side by side

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. — Warning letters0

SQUARE PHARMS PLC — Warning letters0

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. — Recalls205

SQUARE PHARMS PLC — Recalls0

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. — Approval records0

SQUARE PHARMS PLC — Approval records1

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. — Form 483s0

SQUARE PHARMS PLC — Form 483s0

Timeline

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.

Most recent FDA action: August 19, 2026

Full history →

SQUARE PHARMS PLC

Most recent FDA action: July 9, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. vs SQUARE PHARMS PLC: FDA Enforcement Comparison." Argus HQ, accessed August 30, 2026. https://argushq.ai/compare/philips-medical-systems-nederland-b-v-vs-square-pharms-plc

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗